Net profit of Supriya Lifescience declined 3.40% to Rs 36.93 crore in the quarter ended March 2024 as against Rs 38.23 crore during the previous quarter ended March 2023. Sales rose 11.18% to Rs 158.18 crore in the quarter ended March 2024 as against Rs 142.27 crore during the previous quarter ended March 2023.
For the full year,net profit rose 32.55% to Rs 119.11 crore in the year ended March 2024 as against Rs 89.86 crore during the previous year ended March 2023. Sales rose 23.74% to Rs 570.37 crore in the year ended March 2024 as against Rs 460.94 crore during the previous year ended March 2023.
| Particulars | Quarter Ended | Year Ended |
| | Mar. 2024 | Mar. 2023 | % Var. | Mar. 2024 | Mar. 2023 | % Var. |
| Sales | 158.18 | 142.27 | 11 | 570.37 | 460.94 | 24 |
| OPM % | 35.08 | 38.69 | - | 30.33 | 27.96 | - |
| PBDT | 57.08 | 56.30 | 1 | 181.50 | 135.31 | 34 |
| PBT | 53.17 | 53.29 | 0 | 165.69 | 123.49 | 34 |
| NP | 36.93 | 38.23 | -3 | 119.11 | 89.86 | 33 |